Skip to main content

Selected Grants


1/3 CTSA UM1 at Duke University

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2032

Liposomal Amphotericin B and Flucytosine Antifungal Strategies for Talaromycosis (LAmB-FAST) - R01

ResearchAdvisor · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2031

Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC)

ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2023 - 2028

Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency

ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2023 - 2027

2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC

ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2026

Educational Resources to Support FDA's Patient-Focused Drug Development Guidance Series

ResearchAdvisor · Awarded by University of North Carolina - Chapel Hill · 2024 - 2026

Rediscover ICU

ResearchPrincipal Investigator · Awarded by Society of Critical Care Medicine · 2024 - 2025

CURE ID

ResearchPrincipal Investigator · Awarded by Society of Critical Care Medicine · 2024 - 2024

Sepsis-AKI Learning Lab

ResearchPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2023 - 2023

External Relationships


  • Association for Clinical and Translational Science
  • Bioscape Digital
  • CR Forum
  • Emory University
  • Heart Failure Collaboratory/Inova
  • Journal of Clinical and Translational Science
  • King Saud Bin Abdulaziz University for Health Sciences
  • Oregon Health and Science University
  • Regeneron Pharmaceuticals
  • Rocket Pharma
  • University at Buffalo
  • University of Illinois in Chicago
  • University of Kentucky
  • University of Massachusetts Worcester
  • University of Puerto Rico
  • University of Wisconsin, Madison
  • Vanderbilt University Medical Center

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.